These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 25372701)
41. Early-life environment, developmental immunotoxicology, and the risk of pediatric allergic disease including asthma. Dietert RR; Zelikoff JT Birth Defects Res B Dev Reprod Toxicol; 2008 Dec; 83(6):547-60. PubMed ID: 19085948 [TBL] [Abstract][Full Text] [Related]
42. Developmental immunotoxicity investigations in the SD rat following pre- and post-natal exposure to cyclosporin. Barrow PC; Horand F; Ravel G Birth Defects Res B Dev Reprod Toxicol; 2006 Oct; 77(5):430-7. PubMed ID: 17066415 [TBL] [Abstract][Full Text] [Related]
43. Evaluation of OECD screening tests 421 (reproduction/developmental toxicity screening test) and 422 (combined repeated dose toxicity study with the reproduction/developmental toxicity screening test). Reuter U; Heinrich-Hirsch B; Hellwig J; Holzum B; Welsch F Regul Toxicol Pharmacol; 2003 Aug; 38(1):17-26. PubMed ID: 12878050 [TBL] [Abstract][Full Text] [Related]
44. Utilization of juvenile animal studies to determine the human effects and risks of environmental toxicants during postnatal developmental stages. Brent RL Birth Defects Res B Dev Reprod Toxicol; 2004 Oct; 71(5):303-20. PubMed ID: 15505806 [TBL] [Abstract][Full Text] [Related]
45. A detailed study of developmental immunotoxicity of imidacloprid in Wistar rats. Gawade L; Dadarkar SS; Husain R; Gatne M Food Chem Toxicol; 2013 Jan; 51():61-70. PubMed ID: 23000444 [TBL] [Abstract][Full Text] [Related]
46. A comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirements. Giannakou C; Park MV; de Jong WH; van Loveren H; Vandebriel RJ; Geertsma RE Int J Nanomedicine; 2016; 11():2935-52. PubMed ID: 27382281 [TBL] [Abstract][Full Text] [Related]
47. Developmental immunotoxicity in male rats after juvenile exposure to ethanol. Tonk EC; Verhoef A; Gremmer ER; van Loveren H; Piersma AH Toxicology; 2013 Jul; 309():91-9. PubMed ID: 23623904 [TBL] [Abstract][Full Text] [Related]
48. The T-dependent antibody response to keyhole limpet hemocyanin in rodents. Plitnick LM; Herzyk DJ Methods Mol Biol; 2010; 598():159-71. PubMed ID: 19967512 [TBL] [Abstract][Full Text] [Related]
49. Feasibility of the extended one-generation reproductive toxicity study (OECD 443). Fegert I; Billington R; Botham P; Carney E; FitzGerald RE; Hanley T; Lewis R; Marty MS; Schneider S; Sheets LP; Stahl B; van Ravenzwaay B Reprod Toxicol; 2012 Nov; 34(3):331-9. PubMed ID: 22677474 [TBL] [Abstract][Full Text] [Related]
50. Recent progress and diverse effects in developmental immunotoxicology: overview of a symposium at the 46th Annual SOT Meeting, Charlotte, NC. Rooney AA; Yang Y; Makris SL J Immunotoxicol; 2008 Oct; 5(4):395-400. PubMed ID: 19404873 [TBL] [Abstract][Full Text] [Related]
51. Approaches to the evaluation of chemical-induced immunotoxicity. Krzystyniak K; Tryphonas H; Fournier M Environ Health Perspect; 1995 Dec; 103 Suppl 9(Suppl 9):17-22. PubMed ID: 8635435 [TBL] [Abstract][Full Text] [Related]
52. An enhanced tiered toxicity testing framework with triggers for assessing hazards and risks of commodity chemicals. Plunkett LM; Kaplan AM; Becker RA Regul Toxicol Pharmacol; 2010 Dec; 58(3):382-94. PubMed ID: 20709129 [TBL] [Abstract][Full Text] [Related]
53. Guidance on the selection of cohorts for the extended one-generation reproduction toxicity study (OECD test guideline 443). Moore NP; Beekhuijzen M; Boogaard PJ; Foreman JE; North CM; Palermo C; Schneider S; Strauss V; van Ravenzwaay B; Poole A Regul Toxicol Pharmacol; 2016 Oct; 80():32-40. PubMed ID: 27245879 [TBL] [Abstract][Full Text] [Related]
54. A modular one-generation reproduction study as a flexible testing system for regulatory safety assessment. Vogel R; Seidle T; Spielmann H Reprod Toxicol; 2010 Apr; 29(2):242-5. PubMed ID: 19808091 [TBL] [Abstract][Full Text] [Related]
55. A proposed testing framework for developmental immunotoxicology (DIT). Holsapple MP; Burns-Naas LA; Hastings KL; Ladics GS; Lavin AL; Makris SL; Yang Y; Luster MI Toxicol Sci; 2005 Jan; 83(1):18-24. PubMed ID: 15456913 [TBL] [Abstract][Full Text] [Related]
56. Current developments in reproductive toxicity testing of pesticides. Cooper RL Reprod Toxicol; 2009 Sep; 28(2):180-7. PubMed ID: 19409482 [TBL] [Abstract][Full Text] [Related]
57. Utilization of animal studies to determine the effects and human risks of environmental toxicants (drugs, chemicals, and physical agents). Brent RL Pediatrics; 2004 Apr; 113(4 Suppl):984-95. PubMed ID: 15060191 [TBL] [Abstract][Full Text] [Related]
58. Principles of risk assessment for determining the safety of chemicals: recent assessment of residual solvents in drugs and di(2-ethylhexyl) phthalate. Hasegawa R; Koizumi M; Hirose A Congenit Anom (Kyoto); 2004 Jun; 44(2):51-9. PubMed ID: 15198717 [TBL] [Abstract][Full Text] [Related]
59. Sensitivity of different generations and developmental stages in studies on reproductive toxicity. Schulz F; Batke M; Mangelsdorf I; Pohlenz-Michel C; Simetska N; Lewin G Toxicol Lett; 2014 Apr; 226(2):245-55. PubMed ID: 24525464 [TBL] [Abstract][Full Text] [Related]
60. The use of the rat in developmental immunotoxicology studies. Chapin RE Hum Exp Toxicol; 2002; 21(9-10):521-3. PubMed ID: 12458910 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]